SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories informs about newspaper clippings

27 Jul 2020 Evaluate

Ind-Swift Laboratories has informed that it has enclosed the clips of the Newspapers, ‘The Financial Express and Jansatta' dated 26.07.2020 in which Standalone and Consolidated Un-Audited Financial Results of the Company for the Quarter ended on June 30, 2020 has been published, pursuant to Regulation 47 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. The said Un-Audited Financial Results were considered, approved and taken on record by the Board of Directors, in their meeting held on July 25, 2020.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

193.75 4.95 (2.62%)
23-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1867.80
Dr. Reddys Labs. 1301.30
Cipla 1433.10
Zydus Lifesciences 1112.10
Lupin 2356.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: